Quote:

---

Quote:

---

This combination is tailored for patients whose tumors express CCR5

---

Does this tailoring insure that those genetically inappropriate to the goals are excluded so as not to dilute efficacy?

---

If they are testing for CCR5 expression and it certainly looks like it, then it would exclude CCR5 delta 32 deletion double allele patients but not single allele.